ArticleMolecular therapy. Methods & clinical development2021

Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II.

Joo-Hyun Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.